Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



GEN Podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

Early in 2012 Mary Ann Liebert, Inc. publishers will launch Disruptive Science and Technology, a bimonthly peer-reviewed journal that will publish game-changing research that has the potential to significantly improve human health, well-being, and productivity. The journal will present new and innovative results, essential data, cutting-edge discoveries, thorough syntheses and analyses, and publish out-of-the-box concepts.


During this week’s podcast, Dr. Alan Russell, founding director of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh and editor in chief of Disruptive Science and Technology, talks about the need for such a journal. He discusses the key journal topics and describes how the journal’s articles will exemplify "game-changing" research.

Alan Russell (Ph.D. in Biological Chemistry, 1987, Imperial College of Science and Technology, University of London) is a Distinguished University Professor of Surgery and the Founding Director of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh. Further, he holds positions as Professor in the departments of Bioengineering, Chemical Engineering and Rehabilitation Science and Technology. In addition to his appointments at the University, Dr. Russell is the Executive Director of the Pittsburgh Tissue Engineering Initiative, Inc., as well as a consultant for UPMC's International and Commercial Services Division. He has founded three biotechnology companies; ICX Agentase LLC, NanoSembly LLC, and O2Cyte LLC, and was also the Founding President of the 3,000-member Tissue Engineering and Regenerative Medicine International Society.

For the last 15 years, the Russell laboratory has been discovering what can be achieved by exploiting the rich interface of chemistry, biology, and materials. Dr. Russell's work has impacted fields as diverse as chemical and polymer synthesis to tissue engineering and homeland defense. Dr. Russell has pioneered how to make polymers from enzymes and how to incorporate enzymes into bulk polymers. In a series of discoveries, Dr. Russell's laboratory has found how to meld the synthetic and biological worlds.


  • Add a comment
  • Click here to Login or to Register for free. You will be taken back to your selected item after Login/Registration.

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll